ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-66 Cr | ₹-44 Cr | ₹-24 Cr | ₹-9.46 Cr | ₹-8.97 Cr |
What is the latest Cash Flow from Financing Activities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-66 Cr |
| Mar2024 | ₹-44 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹-9.46 Cr |
| Mar2021 | ₹-8.97 Cr |
How is Cash Flow from Financing Activities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-66 Cr | Negative | |
| Mar2024 | ₹-44 Cr | Negative | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹-9.46 Cr | Negative | |
| Mar2021 | ₹-8.97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹20,589.8 Cr | -1.8% | -5.5% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -1.8% |
-5.5% |
-7.3% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses